Cancer antigen 125 levels and increased risk of new-onset atrial fibrillation

Yucel H., Kaya H., Zorlu A., Yildirimli K., Sancakdar E., Gunes H., ...More

HERZ, vol.40, pp.119-124, 2015 (SCI-Expanded) identifier identifier

  • Publication Type: Article / Article
  • Volume: 40
  • Publication Date: 2015
  • Doi Number: 10.1007/s00059-014-4148-4
  • Journal Name: HERZ
  • Journal Indexes: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Page Numbers: pp.119-124
  • Keywords: Cancer antigen 125, Heart failure, Atrial fibrillation, Systolic heart failure, Prediction, CHRONIC HEART-FAILURE, CARBOHYDRATE ANTIGEN-125, PROGNOSTIC-SIGNIFICANCE, CA-125, INFLAMMATION, DISEASE, CA125
  • Dokuz Eylül University Affiliated: No

Abstract

Elevated cancer antigen 125 (CA-125) levels are associated with cardiopulmonary disorders such as acute and chronic heart failure (HF), coronary artery disease, chronic obstructive pulmonary disease, and atrial fibrillation (AF). The development of atrial fibrillation (AF) is related to morbidity and mortality in patients with HF: therefore, it is important to identify patients with increased risk for development of AF. We investigated whether plasma CA-125 levels in patients with hospitalized systolic HF could predict the development of AF.